F2 and hepatocellular carcinoma: ALBI, albumin–bilirubin; CRP, C-reactive protein; HCC, hepatocellular carcinoma; LS, liver stiffness; MELD–Na, model for end-stage liver disease sodium; NLR, neutrophil-to-lymphocyte ratio; PT, prothrombin activity; T.Bil, total bilirubin; TC, total cholesterol